Metraipolis › archive › dc_e7cc3858fc8d

TSC22D4 drives clear cell renal cell carcinoma progression and therapy resistance by stabilizing NRF2 through KEAP1 disruption — Europe PMC PMID:42248840

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42248840
DOI
10.1038/s41419-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-10-31T19:08:28.745Z
SHA-256 of the archived text
fb68c09f891b8f025447540b6059c06225c3e1f289c0caafc17b04a0469f1bd9
Stable URL of this page
https://metraipolis.com/documento/dc_e7cc3858fc8d

How to cite

TSC22D4 drives clear cell renal cell carcinoma progression and therapy resistance by stabilizing NRF2 through KEAP1 disruption — Europe PMC PMID:42248840 — Europe PMC (en), https://europepmc.org/article/MED/42248840 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e7cc3858fc8d (Metraipolis archive dc_e7cc3858fc8d, sha256 fb68c09f891b8f025447540b6059c06225c3e1f289c0caafc17b04a0469f1bd9)
BibTeX
@misc{dce7cc3858fc8d,
  title = {TSC22D4 drives clear cell renal cell carcinoma progression and therapy resistance by stabilizing NRF2 through KEAP1 disruption — Europe PMC PMID:42248840},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42248840},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e7cc3858fc8d; sha256 fb68c09f891b8f025447540b6059c06225c3e1f289c0caafc17b04a0469f1bd9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42248840. Agents can read the archived copy with the MCP tool read_document.